Get in touch with us!












      I accept conditions of use and privacy policy of this website.

    I want to receive updated information on the latest news.

    Get in touch with us!












        I accept conditions of use and privacy policy of this website.

      I want to receive updated information on the latest news.

      An Overview

      ANTIBIOTIC | ANTIINFECTIVE AGENT
      TETRACYCLINE ANTIBIOTIC

      Minocycline is a second-generation, semisynthetic tetracycline antibiotic with broad-spectrum activity against gram-positive and gram-negative bacteria.

      Structural modifications improve its potency over earlier tetracyclines.

      Available in oral, topical, IV, and subgingival forms, it enters bacteria via porin channels and blocks protein synthesis by inhibiting tRNA binding to the 30S ribosome.

      Its long half-life (11–23 h) supports sustained levels, making it effective for both acute and chronic infections.

      minociclina f

      Description / Use

      Properties

      Advantages

      • Manufactured in Portugal – EU GMP
      • CEP available
      • US DMF available
      • EP / USP compliant
      • Established commercial manufacturing
      • Dedicated regulatory & technical support
      • Global supply capability

      Final Product Innovator Presentations

      • Topical: Aerosol, Foam 1.5% and 4% Base
      • Injectable: Injection 100 mg Base/Vial
      • Oral:
        • Tablets: 50, 75 and 100 mg
        • Tablet, extended release: 45, 55, 65, 80, 90, 105, 115 and 135 mg
        • Hard capsules: 100 mg

      Functional benefits

      • Comprehensive nitrosamine risk assessment
      • API-related nitrosamine monitoring strategy established
      • Analytical control according to applicable regulatory requirements
      • Documentation available to support customer regulatory submissions

      * Items covered by valid patents are not offered or supplied for commercial use. Products under patent are available for R&D use only.

      Certifications

      Good Manufacturing Practice
      EMA
      U.S. FOOD & DRUG Administration
      Ministry of Food and Drug Safety (MFDS) of Republic of Korea
      Pharmaceuticals and Medical Devices Agency - Japan
      Infarmed (National Authority of Medicines and Health Products)
      ISO14001

      Certifications of the API

      National Medical Products Administration
      Pharmaceuticals and Medical Devices Agency - Japan
      Ministry of Food and Drug Safety (MFDS) of Republic of Korea
      TFDA

      Our API

      Minocycline

      • Our API minocycline is manufactured in accordance with cGMP and stringent international quality standards.

      Quality

      • Our quality control follows every stage from development of analytical methods to the control of manufacturing process, enabling us to achieve rigorous and stringent results in accordance with injectables parameters, even under aseptic conditions.

       

      Samples available

      Contact Us

      For more information
      about the products.